MT-103
Wet age‑related macular degeneration
PreclinicalActive
Key Facts
About MabTics
Innovative antibody platform focused on vessel normalization for oncology, vascular, and eye diseases.
View full company profileTherapeutic Areas
Other Wet age‑related macular degeneration Drugs
| Drug | Company | Phase |
|---|---|---|
| EyeStrong™ | Lamark Biotech | Preclinical |